Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, November 27, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Antibiotic Resistance Threatens Future of Modern Medicine
Overuse and misuse of antibiotics, one of the key contributors to antimicrobial resistance (AMR).
Powerful Method To Speed Cancer Drug Discovery Unveiled
The new method lets researchers identify weak and previously undetectable interactions between proteins inside living cells.
Translating Research: New Drugs from Fish Oil Could Aid Artery Repair
Every year, more than a half-million Americans undergo procedures to have a narrowed coronary artery propped open with a small metal mesh tube, or stent.
Direct Drug Screening Of Biopsies Could Overcome Resistance
Combining genetic with pharmacologic screening of tumors may enable truly individualized treatment regimens.
Almac Announces Launch of CLIA Validated Next Generation Sequencing Assay
P53 considered important biomarker for cancer drug discovery.
Next-Gen Melanoma Drug Excels in Lab Tests
Anti-cancer activity was reported in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733.
Blood Test Could Reduce Antibiotic Use
A new blood biomarker test that indicates whether bacteria is the cause of a patient’s lung infection is now being studied at UPMC Presbyterian.
New Targets and Test to Develop Treatments for Memory Disorders
The study focuses on kinesin, a molecular motor protein that plays a role in the transport of other proteins throughout a cell.
Drugging the Undruggable
Discovery opens up possibility of slowing cancer spread.
Classification of Gene Mutations in Neuroblastoma
Penn Medicine and CHOP experts define riskier mutations in neuroblastoma, setting stage for clinical trial.

Screening for Chemical Tools: Considerations on Compound Screening Collections, Assay Development and High-throughput Screening
Dominique Audenaert, VIB - Ghent University, speaking at European Lab Automation 2012

Multi-analyte Procedures for Target Screening and Quantification of Drugs in Blood using LC-MS/MS: Possibilities and Limitations
Hans Maurer, Saarland University, speaking at European Lab Automation 2012.

Sample Management and HTS: Convergent Platforms and Universal Solutions to Simplify the Integration Challenge
Chris Walsh, Brooks Life Science Systems, speaking at European Lab Automation 2012

Dynamic Cell Culture for Drug Discovery: Stretching Mechanotransduction from the Lung to the Lab
Dr. Sanjit Nirmalanandhan, University of Kansas Medical Center, speaking at Cell Culture 2012.

ESPRIT: High Throughput Screening for Soluble Expression Constructs of Difficult-to-express Proteins
Darren Hart, European Molecular Biology Laboratory, speaking at European Lab Automation 2012

Fragment Based de novo Ligand Design: A Valuable Optimisation Tool in Fragment Based Lead Discovery
Peter Johnson, University of Leeds, speaking at Discovery Chemistry Congress 2012.

Fragment-Based Drug Discovery - Getting in Shape
Doris Hafenbradl, Biofocus, speaking at Discovery Chemistry Congress 2012.

The Versatility of Fragment Screening Approaches and the Application of Fragment Binding Information in Durg Discovery
Stefan Geschwindner, AstraZeneca, speaking at Discovery Chemistry Congress 2012.

Challenges of an Open Access Screening Platform in Academia
Edgar Specker, Leibniz Institute of Molecular Pharmacology, speaking at European Lab Automation 2012

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 249
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv